Sponsors & CROs


Let’s bring clinical trials closer to the people they’re designed to serve.

Contact Our Partnership Team

Sponsors & CROs

Your Trials. Our Community Reach.

Your Trials. Our Community Reach.

At Orizzonte, we offer sponsors and CROs a new way to run clinical trials—faster, more representative, and rooted in patient trust. By delivering research through GP practices across the UK, we help you reach real-world patients where they already receive care.

Why Partner with Orizzonte

Accelerated Recruitment
Our access to GP patient records (EMIS and SystemOne) enables real-time eligibility screening and rapid patient identification.

Improved Retention
Patients engage more consistently when trials are delivered through their trusted GP, with most visits taking place locally.

Increased Diversity & Inclusion
Our network spans urban, rural, and multi-ethnic communities, supporting diverse enrolment reflective of the real world.

Regulatory Confidence
All sites are GCP compliant, MHRA-ready, and supported by a central team for quality assurance, ethics, and regulatory coordination.

Operational Efficiency
Pre-qualified sites, streamlined onboarding, and embedded research teams mean trials start faster and run smoother.

What We Offer

Real-World Feasibility
Patient population insights directly from GP systems, ensuring the right patients, right sites, and right conditions.

End-to-End Trial Delivery
In-person, hybrid, and decentralised visit support across primary care settings, fully integrated with sponsor CTMS and EDC systems.

Local Trial Teams
Research-trained GPs, dedicated study coordinators, and experienced research nurses supporting every site.

Decentralised Trial Support
Flexible visit models with options for home visits, virtual appointments, and remote monitoring.

Accelerated Recruitment

Our access to GP patient records (EMIS and SystemOne) enables real-time eligibility screening and rapid patient identification.

Improved Retention

Patients engage more consistently when trials are delivered through their trusted GP, with most visits taking place locally.

Increased Diversity & Inclusion

Our network spans urban, rural, and multi-ethnic communities, supporting diverse enrolment reflective of the real world.

Regulatory Confidence

All sites are GCP compliant, MHRA-ready, and supported by a central team for quality assurance, ethics, and regulatory coordination.

Operational Efficiency

Pre-qualified sites, streamlined onboarding, and embedded research teams mean trials start faster and run smoother. Why Partner with Orizzonte

Empowering clinicians to become research-active is not just about advancing science — it’s about transforming care at its core

Dr. Aries Maximus Ogbuokiri

COO

Empowering clinicians to become research-active is not just about advancing science — it’s about transforming care at its core

Dr. Aries Maximus Ogbuokiri

COO

Our Network of Collaborators

Who we work with

Biotechs
Pharmaceutical Industry
Academia
NHS

Latest News & Articles

Dr Gillian Hood

Diabetes Research Manager at Barts & the London School of Medicine and Dentistry, Queen Mary, University of London

Akash Patel

Consultant Trauma and Orthopaedic Surgeon at RoyalFreeLondonNHSFoundation Trust and Associate professor at University College London

Dr Robin Wilson

Consultant Psychiatrist at Priory Roehampton

Aries Maximus Ogbuokiri

Founder & Chief Operating Officer

Read bio...
Read bio...
Dr Zuhaib Keekeebhai

Lead Principal Investigator – Primary Care Trials

Read bio...
Read bio...

Connect with us

Who we work with

Pharmaceuticals
Hospitals
Academia

Who we work with

Pharmaceuticals
Hospitals
Academia

Why It Matters

Reduced Trial Delays
Evidence-based site selection helps avoid underperforming sites and recruitment shortfalls.

Real-World Representation
Our network includes practices in urban, rural, and underserved regions—ensuring diversity in study populations.

Sponsor Confidence
Data-driven feasibility and operational readiness give sponsors the insight they need for confident site selection.


Let’s bring clinical trials closer to the people they’re designed to serve.

Contact Our Partnership Team
Contact Us
Contact Us

Aries is a clinical research leader with a background in emergency nursing and a passion for
making trials more accessible through community-based models.

He founded Orizzonte to integrate clinical research into UK primary care, helping sponsors and
CROs reach diverse, local populations more effectively.

Aries has led research operations across both NHS and private sectors, including building the
research unit at South London and Maudsley NHS Foundation Trust and expanding delivery
capacity at Barnet and Chase Farm Hospitals.

He holds a Master’s in Clinical Research Delivery from King’s College London and brings deep
expertise in patient engagement, regulatory delivery, and cross-sector collaboration.

Founder & Chief Operating Officer Aries Maximus Ogbuokiri
Close

Dr Keekeebhai is an experienced GP and digital health leader dedicated to integrating research
into everyday primary care. As Lead Principal Investigator at Orizzonte, he oversees trial delivery
across our GP network, ensuring quality and compliance.

He is a GP partner and PI at West Green Surgery, a key Orizzonte hub. He also serves as Regional
Clinical Lead (London) for NHS England’s Digital First Primary Care programme and as a Specialist
Medical Advisor to the CQC.

Formerly Chief Clinical Information Officer, he focused on safe, data-driven tech adoption.
His work bridges frontline care, regulation, and digital innovation to shape a modern, patient-centred
research environment.

Lead Principal Investigator – Primary Care Trials Dr Zuhaib Keekeebhai
Close